Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fluorinated Galactoses Inhibit Galactose-1-Phosphate Uridyltransferase and Metabolically Induce Galactosemia-like Phenotypes in HEK-293 Cells.

Cells - 3 Mar 2020

Janes Verena, Grabany Simona, Delbrouck Julien, Vincent Stephane P, Gottschalk Johannes, Elling Lothar, Hanisch Franz-Georg

Abstract excerpt

Genetic defects of human galactose-1-phosphate uridyltransferase (hGALT) and the partial loss of enzyme function result in an altered galactose metabolism with serious long-term developmental impairment of organs in classic galactosemia patients. In search for cellular pathomechanisms induced by the stressor galactose, we looked for ways to induce metabolically a galactosemia-like phenotype by hGALT inhibition in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galactose
Share to Galactosemias

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycosylation

Share to HEK293 Cells

Share to Phenotype

Share to UTP-Hexose-1-Phosphate Uridylyltransferase

Source

Open in PubMed Open full text

Identifiers

PMID: 32138379
DOI: 10.3390/cells9030607
PMCID: PMC7140460

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fluorinated Galactoses Inhibit Galactose-1-Phosphate Uridyltransferase and Metabolically Induce Galactosemia-like Phenotypes in HEK-293 Cells.PMID 32138379Read ↗

Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.Semantic proximity Read ↗

Current and Future Treatments for Classic GalactosemiaSemantic proximity Read ↗

Reshaping the Treatment Landscape of a Galactose Metabolism DisorderSemantic proximity Read ↗

Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.Semantic proximity Read ↗

Sweet and sour: an update on classic galactosemiaSemantic proximity Read ↗

Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and TreatmentSemantic proximity Read ↗

The unfolded protein response has a protective role in yeast models of classic galactosemia.Semantic proximity Read ↗

Hereditary galactosemia.Semantic proximity Read ↗

Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose.Semantic proximity Read ↗

Pathophysiology and management of classic galactosemic primary ovarian insufficiencySemantic proximity Read ↗

Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants.Semantic proximity Read ↗

The molecular biology of galactosemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.